🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12361+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12361 recruiting trials

RecruitingNCT06302270

CFTR Modulators in Pregnancy and Postpartum

🏥 Region Stockholm📍 1 site📅 Started Mar 2024View details ↗
NARecruitingNCT06278194

Masseter Muscle Thickness in Gasser Ganglion Radiofrequency Treatment

👨‍⚕️ Tuba Tanyel Saraçoğlu, MD, Başakşehir Çam & Sakura City Hospital📍 1 site📅 Started Mar 2024View details ↗
RecruitingNCT06402682

Management of Esophageal Atresia With Right Aortic Arch: Is the Side of Approach Important?

🏥 Fondation Lenval📍 1 site📅 Started Mar 2024View details ↗
RecruitingNCT06342414

An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer

👨‍⚕️ Ajay Goel, PhD, City of Hope Medical Center📍 5 sites📅 Started Mar 2024View details ↗
Phase 2RecruitingNCT04597437

Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE)

👨‍⚕️ Aileen Chang, MD, George Washington University📍 2 sites📅 Started Mar 2024View details ↗
RecruitingNCT06280313

Impact of Splenectomy on the Efficacy of Targeted Therapy and Immunotherapy in Unresectable HCC Patients With Cirrhotic Portal Hypertension

👨‍⚕️ Zhiyong Huang, Tongji Hospital📍 1 site📅 Started Mar 2024View details ↗
Phase 3RecruitingNCT05835310

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

🏥 AstraZeneca📍 96 sites📅 Started Mar 2024View details ↗
NARecruitingNCT06268496

Efficacy and Tolerability of the Tested Formula After 3 Months in Treatment of Facial Hyperpigmentation of 3 Origins

👨‍⚕️ Sergio Schalka, Medcin Instituto da Pele Ltda📍 1 site📅 Started Mar 2024View details ↗
Phase 1RecruitingNCT06321250

A Study of JMKX003948 Tablets in Patients With Renal Cell Carcinoma

👨‍⚕️ Jun Guo, Peking University Cancer Hospital & Institute📍 1 site📅 Started Mar 2024View details ↗
RecruitingNCT06409013

Evaluation of Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography in Patients With Sarcoma

👨‍⚕️ Matthew T. Houdek, M.D., Mayo Clinic in Rochester📍 1 site📅 Started Mar 2024View details ↗
Phase 2RecruitingNCT06318286

Study of Pembrolizumab Plus Chemotherapy With Lenvatinib for Malignant Pleural Mesothelioma

👨‍⚕️ Kozo Kuribayashi, MD, PhD, Department of Respiratory Medicine and Hematology, Hyogo Medical University Hospital📍 1 site📅 Started Mar 2024View details ↗
Phase 2RecruitingNCT06023641

Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease

👨‍⚕️ Alberto Pappo, MD, St. Jude Children's Research Hospital📍 3 sites📅 Started Mar 2024View details ↗
Phase 1RecruitingNCT06327685

Avapritinib With Decitabine in Patients With SM-AHN

👨‍⚕️ Andrew Kuykendall, MD, Moffitt Cancer Center📍 7 sites📅 Started Mar 2024View details ↗
RecruitingNCT06321003

SYsteMatical Trained learnIng aLgorithms for Oral carcInogenesiS Interpretation by Optical Coherence Tomography

👨‍⚕️ Vera Panzarella, University of Palermo📍 1 site📅 Started Mar 2024View details ↗
RecruitingNCT06377462

Multicenter, Interdisciplinary National VEXAS Registry With Accompanying Biomaterial Collection

👨‍⚕️ Katja Sockel, Dr. med., TU Dresden📍 13 sites📅 Started Mar 2024View details ↗
NARecruitingNCT06765564

Clinical Study of Induced Pluripotent Stem Cells Derived Motor Neuron Precursor Cell Therapy for Amyotrophic Lateral Sclerosis (ALS)

🏥 Shanghai East Hospital📍 1 site📅 Started Mar 2024View details ↗
Phase 2RecruitingNCT06175000

Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response

👨‍⚕️ Prakash Ambady, MD, Providence Health & Services📍 7 sites📅 Started Mar 2024View details ↗
Phase 4RecruitingNCT06484530

Gene-guided N-acetyl Cysteine for Prophylaxis of Anti-tuberculous Drug- Induced Hepatitis

👨‍⚕️ Supot Nimanong, Mahidol University📍 1 site📅 Started Mar 2024View details ↗
Phase 2RecruitingNCT05231122

Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer

👨‍⚕️ Emese Zsiros, Roswell Park Cancer Institute📍 2 sites📅 Started Mar 2024View details ↗
Phase 3Enrolling by InvitationNCT06731582

Nicotinamide Supplementation in Glaucoma

🏥 Singapore Eye Research Institute📍 2 sites📅 Started Mar 2024View details ↗
← PreviousPage 317 of 619Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →